Natural gas stocks and ETNs like United States Natural Gas Fund (NYSE: UNG) and VelocityShares 3x Long Natural Gas ETN (NYSE: UGAZ) may see an uncommon catalyst this week — a solar eclipse.
On Monday, the moon, sun and Earth will be in perfect alignment for some of the continental United States, with the moon temporarily blocking the Earth from the sun. America’s solar power will be reduced by more than 10,000 megawatts, causing nat gas generators to help fill the void in energy demand.
Top Energy Stocks To Own For 2019: Guidewire Software, Inc.(GWRE)
Advisors' Opinion:- [By Motley Fool Staff]
Guidewire Software, Inc. (NYSE:GWRE)Q3 2018 Earnings Conference CallJune 5, 2018, 5:00 p.m. ET
Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:Operator
- [By Max Byerly]
Shares of Guidewire Software Inc (NYSE:GWRE) have received an average rating of “Buy” from the thirteen research firms that are presently covering the firm, MarketBeat reports. One investment analyst has rated the stock with a sell recommendation, two have assigned a hold recommendation and nine have issued a buy recommendation on the company. The average 1-year price objective among brokerages that have issued ratings on the stock in the last year is $95.00.
- [By Max Byerly]
Verition Fund Management LLC bought a new position in shares of Guidewire Software Inc (NYSE:GWRE) in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund bought 2,731 shares of the technology company’s stock, valued at approximately $221,000.
Top Energy Stocks To Own For 2019: Aurora Cannabis Inc. (ACBFF)
Advisors' Opinion:- [By Sean Williams]
It just so happens that one of Canada's top two players in the cannabis industry, Aurora Cannabis (NASDAQOTH:ACBFF), reported its third-quarter operating results on May 8 and updated investors on what to expect going forward. Given its importance to the domestic Canadian pot industry -- the company expects to generate 430,000 kilograms of cannabis a year at full capacity -- it pays to keep tabs on Aurora's growth and how its projects are progressing. That said, here are the 10 things you should know about Aurora Cannabis' Q3 report.�
- [By Shanthi Rexaline]
Aurora Cannabis Inc (OTC: ACBFF) recently announced a deal to buy MedReleaf Corp (OTC: MEDFF) in an all-cash transaction valued at C$3.2 billion.
- [By Sean Williams]
Perhaps the one company that could give Canopy Growth a run for its money is Aurora Cannabis (NASDAQOTH:ACBFF). Having begun the year with an estimated annual production capacity of just over 100,000 kilograms of cannabis, Aurora Cannabis is now expected to generate 570,000 kilograms a year, when at full capacity. This added capacity comes from its acquisition of CanniMed Therapeutics, its pending all-share buyout of MedReleaf, its joint venture with Alfred Pedersen & Son (known as Aurora Nordic), and its announced 1.2-million-square-foot greenhouse project in Medicine Hat, Alberta, to be known as Aurora Sun.
- [By Keith Speights]
Up until this week, the biggest marijuana stock deal of all time was Aurora Cannabis' (NASDAQOTH:ACBFF) acquisition of CanniMed Therapeutics earlier this year for $852 million. Now, though, another Aurora transaction is taking the No. 1 spot.
- [By ]
The three companies we consider most potent for future growth in value are Canopy Growth Corp. (NYSE:CGC), Aurora Cannabis (OTCQX:ACBFF), and Aphria (OTCQB:APHQF). Canopy is a diversified cannabis company that both produces and sells cannabis products for the Canadian medical cannabis market. The company is well-positioned to start growing for recreational use once it becomes legal. Aurora's focus is also on both growing and selling medical cannabis and produces both psychoactive THC products and medically oriented CBD products. It has an aggressive growth and acquisition strategy, also having conducted the largest acquisition in the cannabis industry when acquiring CanniMed Therapeutics earlier this year. Aphria is another grower and seller of medical marijuana, which conducts its sales through retail stores and wholesale distribution. All three companies have well-positioned themselves in the Canadian market and could be potential target companies for Big Tobacco or Big Alcohol or turn into major market leaders.
- [By Keith Speights]
There have already been several big mergers and acquisitions among Canadian marijuana growers over the last couple of years. The biggest deal so far was Aurora Cannabis' (NASDAQOTH:ACBFF) once-hostile but later�friendly takeover of CanniMed Therapeutics. Now it seems that Aurora might be itching for an even bigger deal.
Top Energy Stocks To Own For 2019: Cross Country Healthcare, Inc.(CCRN)
Advisors' Opinion:- [By Lisa Levin]
Losers Heat Biologics, Inc. (NASDAQ: HTBX) shares tumbled 48.59 percent to close at $1.275 on Thursday after the company priced its $18,000,000 public offering. InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) fell 38.77 percent to close at $8.26 on Thursday. Check-Cap Ltd. (NASDAQ: CHEK) shares tumbled 27.43 percent to close at $8.81. Achaogen, Inc. (NASDAQ: AKAO) dropped 24.76 percent to close at $11.06 in reaction to a disappointing update from an FDA AdCom panel. The FDA panel voted favorably for the company's Plazcomicin for treatment of adults with complicated urinary tract infections, but also voted against the therapy to be used as a treatment for bloodstream infections. Anika Therapeutics, Inc. (NASDAQ: ANIK) shares declined 24.68 percent to close at $34.80 after the company posted downbeat quarterly results. LSC Communications, Inc. (NASDAQ: LKSD) shares fell 24.22 percent to close at $12.64 following wider-than-expected Q1 loss. Cardinal Health, Inc. (NYSE: CAH) fell 21.42 percent to close at $50.80 following downbeat quarterly profit. Horizon Global Corporation (NYSE: HZN) dropped 20.42 percent to close at $6.00 following downbeat quarterly earnings. Hornbeck Offshore Services, Inc. (NYSE: HOS) slipped 20.11 percent to close at $2.90 following wider-than-expected Q1 loss. Esperion Therapeutics, Inc. (NASDAQ: ESPR) fell 19.28 percent to close at $36.93. Esperion Therapeutics stock lost roughly a third of its value Wednesday after the company reported mixed Phase III results for its leading drug candidate, bempedoic acid. JP Morgan downgraded Esperion Therapeutics from Neutral to Underweight. Laredo Petroleum, Inc. (NYSE: LPI) declined 17.77 percent to close at $8.98 after the company reported weaker-than-expected Q1 earnings. The Habit Restaurants, Inc. (NASDAQ: HABT) dipped 16.1 percent to close at $8.60 after the company reported downbeat quarterly results. Arcadia Biosciences, Inc. (N - [By Joseph Griffin]
Cross Country Healthcare, Inc. (NASDAQ:CCRN) has received an average recommendation of “Buy” from the thirteen ratings firms that are presently covering the stock, Marketbeat reports. Seven investment analysts have rated the stock with a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the company. The average 1-year price objective among brokers that have updated their coverage on the stock in the last year is $14.00.
- [By ]
Activist investor Glenn Welling of Engaged Capital LLC, the insurgent investor agitating for changes at TiVo, Rent-a-Center, on Tuesday, May 15, revealed new positions in Aratana Therapeutics Inc. (PETX) , Cross Country Healthcare Inc. (CCRN) and Finisar Corp. (FNSR)
No comments:
Post a Comment